Pfizer, Moderna to Expand Vaccine Studies of Kids 5 to 11: Report

The U.S. Food and Drug Administration has urged Pfizer and Moderna to expand their clinical trials for children 5 to 11 years old, amid cases of heart inflammation among those under 30 years of age who had been vaccinated, The New York Times reported Monday.

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.